3-[(4,4-difluorocyclohexyl)methyl]-5-(methylsulfonyl)-N-(tetrahydro-2H-pyran-4-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyridine-7-carboxamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 咪唑并吡啶类
• 英文名称: 3-[(4,4-difluorocyclohexyl)methyl]-5-(methylsulfonyl)-N-(tetrahydro-2H-pyran-4-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyridine-7-carboxamide
• 英文别名: 3-[(4,4-difluorocyclohexyl)methyl]-5-methylsulfonyl-N-(oxan-4-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyridine-7-carboxamide
• 化学式: C₂₂H₂₆F₅N₃O₄S
• 分子量: 523.524
• InChiKey: XLSJCSBWFXVNRJ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.4
• 重原子数：
  35
• 可旋转键数：
  5
• 环数：
  4.0
• sp3杂化的碳原子比例：
  0.64
• 拓扑面积：
  98.2
• 氢给体数：
  1
• 氢受体数：
  10

反应信息

• 作为产物：
  描述：

  5-chloro-3-(4,4-difluorocyclohexylmethyl)-N-(tetrahydro-2H-pyran-4-yl)-2-trifluoromethylimidazo[1,2-a]pyridine-7-carboxamide 、 sodium methansulfinate 以 N,N-二甲基甲酰胺 为溶剂， 反应 7.0h， 以21%的产率得到3-[(4,4-difluorocyclohexyl)methyl]-5-(methylsulfonyl)-N-(tetrahydro-2H-pyran-4-yl)-2-(trifluoromethyl)imidazo[1,2-a]pyridine-7-carboxamide
  参考文献：
  名称：

  CONDENSED RING HETEROCYCLIC COMPOUND

  摘要：

  公开号：

  EP2881394B1

文献信息

• RING-FUSED HETEROCYCLIC COMPOUND
  申请人：Kyowa Hakko Kirin Co., Ltd.

  公开号：US20150284384A1

  公开（公告）日：2015-10-08

  The ring-fused heterocyclic compound or a pharmaceutically acceptable salt thereof according to the present invention has a T-type calcium channel regulatory effect, and is useful, for example, as a medicament for treating and/or preventing pruritus. The present invention provides a ring-fused heterocyclic compound represented by the following general formula (I) or a pharmaceutically acceptable salt thereof and the like which has a T-type calcium channel regulatory effect and is useful as a therapeutic and/or preventive agent for pruritus, and the like. [wherein, R 1 represents optionally substituted lower alkyl and the like, R 2 represents optionally substituted lower alkyl and the like, R 3 represents the formula (II): (wherein, n represents 0 or 1, R 3a represents a hydrogen atom and the like, R 3b represents a hydrogen atom and the like, and R 3c represents a hydrogen atom and the like) and the like, Q represents a hydrogen atom and the like, and W 1 represents a nitrogen atom and the like, W 2 represents a nitrogen atom and the like]

  根据本发明，环融合杂环化合物或其药学上可接受的盐具有T型钙通道调节作用，例如，可用作治疗和/或预防瘙痒的药物。本发明提供了由以下一般式(I)或其药学上可接受的盐等表示的环融合杂环化合物，具有T型钙通道调节作用，可用作治疗和/或预防瘙痒等疾病的治疗和/或预防剂。其中，R1代表可选取代的低碳基等，R2代表可选取代的低碳基等，R3代表公式(II)：（其中，n代表0或1，R3a代表氢原子等，R3b代表氢原子等，R3c代表氢原子等）等，Q代表氢原子等，W1代表氮原子等，W2代表氮原子等。
• US9540366B2
  申请人：——

  公开号：US9540366B2

  公开（公告）日：2017-01-10
• CONDENSED RING HETEROCYCLIC COMPOUND
  申请人：Kyowa Hakko Kirin Co., Ltd.

  公开号：EP2881394B1

  公开（公告）日：2018-03-21